RHOA and prostate cancer: Of interest, the tumor suppressor maspin has been reported to mediate tumor cell migration through inhibiting Rac1 and Cdc42, but not RhoA GTPase [29], suggesting that targeting the Rac1/Cdc42 pathways by AZA1 could counteract the activity of maspin in prostate cancer cells.